PREMEDICATION USE IN THE PREVENTION OF INFLIXIMAB RELATED INFUSION REACTIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED IN THE HOME SETTING

被引：0
|
作者：
Checkley, Allyson
Kristofek, Loretta
Kile, Samantha
Bolgar, William
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1687
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [1] COMPARISONS OF PREMEDICATION STRATEGIES FOR PREVENTING INFLIXIMAB RELATED INFUSION REACTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Gold, Stephanie L.
    Cohen-Mekelburg, Shirley A.
    Schneider, Yecheskel
    Shen, Nicole T.
    Scherl, Ellen
    Bosworth, Brian P.
    Steinlauf, Adam F.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S109 - S109
  • [2] Premedication Use in Preventing Acute Infliximab Infusion Reactions in Patients with Inflammatory Bowel Disease: A Single Center Cohort Study
    Gold, Stephanie L.
    Cohen-Mekelburg, Shirley
    Schneider, Yecheskel
    Shen, Nicole
    Faggen, Alec
    Rupert, Amanda
    Scherl, Ellen J.
    Bosworth, Brian
    Steinlauf, Adam
    [J]. INFLAMMATORY BOWEL DISEASES, 2017, 23 (10) : 1882 - 1889
  • [3] VEDOLIZUMAB RELATED INFUSION REACTIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED IN AN ALTERNATE CARE SETTING
    Checkley, Allyson
    Kristofek, Loretta
    Bolgar, William
    [J]. INFLAMMATORY BOWEL DISEASES, 2019, 25 : S31 - S31
  • [4] VEDOLIZUMAB RELATED INFUSION REACTIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED IN AN ALTERNATE CARE SETTING
    Checkley, Allyson
    Kristofek, Loretta
    Bolgar, William
    [J]. GASTROENTEROLOGY, 2019, 156 (03) : S44 - S45
  • [5] Premedication and infusion reactions with infliximab: Results from a pediatric inflammatory bowel disease consortium
    Markowitz, JE
    Ferry, GD
    Kirschner, BS
    Winter, HS
    Cohen, SA
    Gold, BD
    Heyman, MB
    Mamula, P
    Shepanski, MA
    Smith, T
    Fain, PL
    Baldassano, RN
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A631 - A631
  • [6] Premedication and infusion reactions with infliximab: Results from a pediatric inflammatory bowel disease consortium
    Jacobstein, DA
    Markowitz, JE
    Kirschner, BS
    Ferry, G
    Cohen, SA
    Gold, BD
    Winter, HS
    Heyman, MB
    Baldassano, RN
    [J]. INFLAMMATORY BOWEL DISEASES, 2005, 11 (05) : 442 - 446
  • [7] PREDICTORS OF ACUTE INFLIXIMAB INFUSION REACTIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Gold, Stephanie L.
    Cohen-Mekelburg, Shirley A.
    Schneider, Yecheskel
    Shen, Nicole T.
    Rupert, Amanda
    Faggen, Alec
    Scherl, Ellen
    Bosworth, Brian P.
    Steinlauf, Adam F.
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S584 - S585
  • [8] Rapid infusion of infliximab biosimilars and the incidence and severity of infusion-related reactions in patients with inflammatory bowel disease
    Rusch, Caroline
    Wood, Marci
    Kennedy, Amanda G.
    Tompkins, Bradley J.
    Frasca, Joseph D.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (11) : 1851 - 1857
  • [9] Infliximab in inflammatory bowel disease: Is premedication necessary?
    Nunez, P.
    Figueroa, C.
    Flores, L.
    Ibanez, P.
    Kronberg, U.
    Lubascher, J.
    Pizarro, G.
    Quera, R.
    Simian, D.
    [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S334 - S335
  • [10] Infliximab in inflammatory bowel disease. Is premedication necessary?
    Paulina Nunez, F.
    Quera, Rodrigo
    Simian, Daniela
    Flores, Lilian
    Figueroa, Carolina
    Ibanez, Patricio
    Kronberg, Udo
    Lubascher, Jaime
    Pizarro, Gonzalo
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2021, 44 (05): : 321 - 329
12345